NCT04891523View on ClinicalTrials.gov

Probiotic Modulation of Oral Microbiota

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

October 24, 2022

Study Completion Date

October 24, 2022

Conditions
Microbial Colonization
Interventions
DIETARY_SUPPLEMENT

Probiotics-O (Burgerstein)

Topical oral treatment with the probiotic Streptococcus salivarius K12 (BIOTICS-O, Burgerstein) in form of a lozenge, daily, during 3 weeks.

OTHER

Placebo [inactivated Probiotics-O (Burgerstein)]

Topical oral treatment with the placebo \[inactivated probiotic Streptococcus salivarius K12 (BIOTICS-O, Burgerstein)\] in form of a lozenge, daily, during 3 weeks.

Trial Locations (1)

1211

Geneva University Hospitals (HUG), Geneva

All Listed Sponsors
lead

Prof. Jacques SCHRENZEL

OTHER

NCT04891523 - Probiotic Modulation of Oral Microbiota | Biotech Hunter | Biotech Hunter